BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19638712)

  • 1. Increased P-selectin expression on platelets and decreased plasma thrombomodulin in Fontan patients.
    Kajimoto H; Nakazawa M; Murasaki K; Hagiwara N; Nakanishi T
    Circ J; 2009 Sep; 73(9):1705-10. PubMed ID: 19638712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased thrombogenesity in patients with cyanotic congenital heart disease.
    Kajimoto H; Nakazawa M; Murasaki K; Mori Y; Tanoue K; Kasanuki H; Nakanishi T
    Circ J; 2007 Jun; 71(6):948-53. PubMed ID: 17526995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in blood coagulation, fibrinolysis, and platelet activation in adult patients after the Fontan procedure.
    Tomkiewicz-Pajak L; Hoffman P; Trojnarska O; Lipczyńska M; Podolec P; Undas A
    J Thorac Cardiovasc Surg; 2014 Apr; 147(4):1284-90. PubMed ID: 23891464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin generation and activation of the thrombomodulin protein C system in open heart surgery depend on the underlying cardiac disease.
    Welters I; Menges T; Ballesteros M; Knothe C; Ruwoldt R; Görlach G; Hempelmann G
    Thromb Res; 1998 Oct; 92(1):1-9. PubMed ID: 9783668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble P-selectin and thrombomodulin-protein C-Protein S pathway in cyanotic congenital heart disease with secondary erythrocytosis.
    Horigome H; Murakami T; Isobe T; Nagasawa T; Matsui A
    Thromb Res; 2003; 112(4):223-7. PubMed ID: 14987915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased plasma P-selectin and decreased thrombomodulin in pulmonary arterial hypertension were improved by continuous prostacyclin therapy.
    Sakamaki F; Kyotani S; Nagaya N; Sato N; Oya H; Satoh T; Nakanishi N
    Circulation; 2000 Nov; 102(22):2720-5. PubMed ID: 11094038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
    Blann AD; Lip GY; Beevers DG; McCollum CN
    Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased blood coagulation and platelet activation in patients with infective endocarditis and embolic events.
    Buyukasýk NS; Ileri M; Alper A; Senen K; Atak R; Hisar I; Yetkin E; Turhan H; Demirkan D
    Clin Cardiol; 2004 Mar; 27(3):154-8. PubMed ID: 15049384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-selectin- and CD63-exposing platelet microparticles reflect platelet activation in peripheral arterial disease and myocardial infarction.
    van der Zee PM; Biró E; Ko Y; de Winter RJ; Hack CE; Sturk A; Nieuwland R
    Clin Chem; 2006 Apr; 52(4):657-64. PubMed ID: 16439610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased soluble selectins as a reflection of activated platelets and endothelium in Legg-Calve-Perthes disease.
    Ismayilov V; Aksoy DY; Sayinalp N; Haznedaroğlu IC; Aksoy MC
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e410-1. PubMed ID: 25000467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
    Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
    Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased lipid peroxidation correlates with platelet activation but not with markers of endothelial cell and blood coagulation activation in patients with antiphospholipid antibodies.
    Martinuzzo ME; Forastiero RR; Kordich L; Carreras LO
    Br J Haematol; 2001 Sep; 114(4):845-51. PubMed ID: 11564073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunction of endothelial protein C activation in severe meningococcal sepsis.
    Faust SN; Levin M; Harrison OB; Goldin RD; Lockhart MS; Kondaveeti S; Laszik Z; Esmon CT; Heyderman RS
    N Engl J Med; 2001 Aug; 345(6):408-16. PubMed ID: 11496851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hemostatic and coagulation factor abnormalities in patients undergoing the Fontan operation.
    Jahangiri M; Kreutzer J; Zurakowski D; Bacha E; Jonas RA
    J Thorac Cardiovasc Surg; 2000 Oct; 120(4):778-82. PubMed ID: 11003762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normothermic versus hypothermic cardiopulmonary bypass: do changes in coagulation differ?
    Boldt J; Knothe C; Welters I; Dapper FL; Hempelmann G
    Ann Thorac Surg; 1996 Jul; 62(1):130-5. PubMed ID: 8678631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke.
    Bédard E; Rodés-Cabau J; Houde C; Mackey A; Rivest D; Cloutier S; Noël M; Marrero A; Côté JM; Chetaille P; Delisle G; Leblanc MH; Bertrand OF
    Stroke; 2007 Jan; 38(1):100-4. PubMed ID: 17122434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of five marker levels of the hemostatic system and endothelial status in normotensive pregnancy and pre-eclampsia.
    Hayashi M; Inoue T; Hoshimoto K; Negishi H; Ohkura T; Inaba N
    Eur J Haematol; 2002; 69(5-6):297-302. PubMed ID: 12460234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of platelet, endothelial cell and blood coagulation activation in leprosy patients with antiphospholipid antibodies.
    Martinuzzo ME; de Larrañaga GF; Forastiero RR; Pelegri Y; Fariña MH; Alonso BS; Kordich LC; Carreras LO
    Clin Exp Rheumatol; 2002; 20(4):477-83. PubMed ID: 12175102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.
    Idorn L; Jensen AS; Juul K; Reimers JI; Johansson PI; Sørensen KE; Ostrowski SR; Søndergaard L
    Pediatr Cardiol; 2013 Feb; 34(2):262-72. PubMed ID: 22843202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis.
    Zhang Q; Zeng C; Fu Y; Cheng Z; Zhang J; Liu Z
    Nephrology (Carlton); 2012 May; 17(4):338-45. PubMed ID: 22295953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.